Xgeva

Xgeva (denosumab) is a prescription medication used to strengthen bones and reduce bone complications in adults with bone metastases from solid tumors. It belongs to the class of bone-modifying agents and is administered via subcutaneous injection. This overview covers key details for informational purposes only.

Xgeva is primarily used to prevent bone fractures, spinal cord compression, and other bone-related complications in patients with bone metastases from solid tumors such as breast or prostate cancer. It may also be prescribed to treat osteoporosis in postmenopausal women at high risk of fractures. The medication works by slowing bone breakdown and increasing bone strength. Patients often ask, 'what is Xgeva used for' to understand its role in managing bone health.

Xgeva helps reduce the risk of bone pain and fractures by stabilizing bone structure and density. Many patients report improved mobility and comfort as their bones become less susceptible to damage. The effects are typically observed over time with regular administration. Some users may experience temporary injection-site reactions, such as redness or swelling.

Xgeva should be administered by a healthcare professional in a clinical setting. Patients with low blood calcium levels should correct this condition before starting treatment. Regular dental check-ups are recommended, as rare cases of jawbone problems have been reported. Inform your doctor about any history of kidney disease or dental issues before use.

Xgeva may interact with other medications that affect bone metabolism, such as bisphosphonates or corticosteroids. Avoid combining it with strong immunosuppressants unless directed by a healthcare provider. Alcohol and tobacco may reduce the effectiveness of bone-strengthening treatments. Always disclose all medications and supplements to your doctor.